日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

TROP2/claudin 程序介导免疫排斥,从而阻碍乳腺癌中的检查点阻断。

Wu Bogang, Thant Win, Bitman Elena, Liu Ting, Liu Jie, Paschalis Eleftherios I, Patel Bidish K, Nawrocki Cole, Xu Katherine H, Nieman Linda T, Ting David T, de Gois Macedo Bruna, Cheng Yang, Jiang Kevin, Sun Fengfei, Thimmiah Nayana, Sun Sheng, Abelman Rachel O, Bossuyt Veerle I, Isakoff Steven J, Spring Laura M, Bardia Aditya, Ellisen Leif W

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya